{ "cik": 1484612, "cik_padded": "0001484612", "entityName": "Outset Medical, Inc.", "fiscal_years": [ { "accn": "0001193125-26-051278", "filed": "2026-02-13", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 798000.0, "cash": 35006000.0, "cost_of_revenue": 72722000.0, "eps_diluted": -5.37, "free_cash_flow": -47125000.0, "gross_profit": 46754000.0, "net_income": -81653000.0, "operating_cash_flow": -46327000.0, "operating_income": -66706000.0, "revenue": 119476000.0, "stockholders_equity": 126952000.0, "total_assets": 264496000.0, "total_liabilities": 137544000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.39132545448458267, "leverage": 1.08343310857647, "net_margin": -0.6834259600254444, "operating_margin": -0.5583213365027285, "revenue_growth_yoy": 0.05090202218332469, "roa_avg2y": -0.3022556363145046, "roa_period_end": -0.3087116629363015, "roe_avg2y": -1.0620077908058085, "roe_period_end": -0.64318009956519 } }, { "accn": "0001193125-26-051278", "filed": "2026-02-13", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 912000.0, "cash": 124014000.0, "cost_of_revenue": 75125000.0, "eps_diluted": -36.96, "free_cash_flow": -117215000.0, "gross_profit": 38564000.0, "net_income": -127976000.0, "operating_cash_flow": -116303000.0, "operating_income": -113375000.0, "revenue": 113689000.0, "stockholders_equity": 26819000.0, "total_assets": 275795000.0, "total_liabilities": 248976000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.33920607974386263, "leverage": 9.283567619970917, "net_margin": -1.1256673908645516, "operating_margin": -0.9972380793216583, "revenue_growth_yoy": -0.12799134810087745, "roa_avg2y": -0.4341142070163298, "roa_period_end": -0.46402581627658224, "roe_avg2y": -1.70970909455262, "roe_period_end": -4.771840859092435 } }, { "accn": "0001193125-26-051278", "filed": "2026-02-13", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3440000.0, "cash": 68509000.0, "cost_of_revenue": 101376000.0, "eps_diluted": -52.28, "free_cash_flow": -134813000.0, "gross_profit": 29000000.0, "net_income": -172797000.0, "operating_cash_flow": -131373000.0, "operating_income": -169770000.0, "revenue": 130376000.0, "stockholders_equity": 122886000.0, "total_assets": 313801000.0, "total_liabilities": 190915000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.22243357673191386, "leverage": 1.5535943882948424, "net_margin": -1.3253743020187765, "operating_margin": -1.302156838681966, "revenue_growth_yoy": 0.13001950162513543, "roa_avg2y": -0.48408216092649553, "roa_period_end": -0.5506579010264467, "roe_avg2y": -0.9368839393183618, "roe_period_end": -1.4061569259313513 } }, { "accn": "0001193125-26-051278", "filed": "2026-02-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 8325000.0, "cash": 73222000.0, "cost_of_revenue": 97542000.0, "eps_diluted": -3.38, "free_cash_flow": -154054000.0, "gross_profit": 17833000.0, "net_income": -162956000.0, "operating_cash_flow": -145729000.0, "operating_income": -161019000.0, "revenue": 115375000.0, "stockholders_equity": 245990000.0, "total_assets": 400115000.0, "total_liabilities": 154125000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.15456554712892742, "leverage": 0.6265498597503963, "net_margin": -1.412403033586132, "operating_margin": -1.3956143011917659, "revenue_growth_yoy": 0.12449075066762831, "roa_avg2y": -0.3773968565701574, "roa_period_end": -0.4072729090386514, "roe_avg2y": -0.5256043259562212, "roe_period_end": -0.6624496930769542 } }, { "accn": "0000950170-25-030045", "filed": "2025-02-28", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3108000.0, "cash": 182348000.0, "cost_of_revenue": 94994000.0, "eps_diluted": -2.89, "free_cash_flow": -133372000.0, "gross_profit": 7608000.0, "net_income": -131935000.0, "operating_cash_flow": -130264000.0, "operating_income": -130519000.0, "revenue": 102602000.0, "stockholders_equity": 374081000.0, "total_assets": 463464000.0, "total_liabilities": 89383000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.07415060135280015, "leverage": 0.2389402295224831, "net_margin": -1.2858911132336601, "operating_margin": -1.2720902126664198, "revenue_growth_yoy": 1.0547111244618004, "roa_avg2y": -0.30424550872657796, "roa_period_end": -0.28467151709733657, "roe_avg2y": -0.37551409583173234, "roe_period_end": -0.35269099473108767 } }, { "accn": "0000950170-24-018093", "filed": "2024-02-21", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9077000.0, "cash": 294972000.0, "cost_of_revenue": 62972000.0, "eps_diluted": -4.85, "free_cash_flow": -108092000.0, "gross_profit": -13037000.0, "net_income": -121492000.0, "operating_cash_flow": -99015000.0, "operating_income": -117467000.0, "revenue": 49935000.0, "stockholders_equity": 328609000.0, "total_assets": 403829000.0, "total_liabilities": 75220000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": -0.26107940322419143, "leverage": 0.22890426007808673, "revenue_growth_yoy": 2.3117787504974134, "roa_avg2y": -0.4936742551224616, "roa_period_end": -0.3008501123000082, "roe_avg2y": 5.575841020698517, "roe_period_end": -0.36971598465045086 } }, { "accn": "0000950170-23-002648", "filed": "2023-02-13", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3293000.0, "cash": 36926000.0, "cost_of_revenue": 32880000.0, "free_cash_flow": -73585000.0, "gross_profit": -17802000.0, "net_income": -68299000.0, "operating_cash_flow": -70292000.0, "operating_income": -70307000.0, "revenue": 15078000.0, "stockholders_equity": -372187000.0, "total_assets": 88366000.0, "total_liabilities": 51107000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": -1.1806605650616793, "revenue_growth_yoy": 6.512705530642751, "roa_period_end": -0.772910395400946, "roe_avg2y": 0.20692371431990633 } }, { "accn": "0000950170-22-001769", "filed": "2022-02-23", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 1766000.0, "cost_of_revenue": 8122000.0, "free_cash_flow": -48208000.0, "gross_profit": -6115000.0, "net_income": -49780000.0, "operating_cash_flow": -46442000.0, "operating_income": -46563000.0, "revenue": 2007000.0, "stockholders_equity": -287950000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": -3.046836073741903, "roe_avg2y": 0.19758398212297598 } }, { "accn": "0001564590-21-014563", "filed": "2021-03-22", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -215937000.0 }, "period_end": "2017-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-051278", "filed": "2026-02-13", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3845", "sic_description": "Electromedical & Electrotherapeutic Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001484612.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001484612.json" }, "ticker": "OM" }